Neuroscience Institute, Loyola University Chicago, 2160 South First Avenue, Maywood, IL 60153, United States.
Department of Molecular Pharmacology and Therapeutics, Loyola University Chicago, 2160 South First Avenue, Maywood, IL 60153, United States.
Neuropharmacology. 2018 Sep 1;139:173-181. doi: 10.1016/j.neuropharm.2018.07.008. Epub 2018 Jul 10.
Increasing evidence suggests that multiple factors can produce effects on the immature brain that are distinct and more long-lasting than those produced in adults. The hypothalamic paraventricular nucleus (PVN) is a region integral to the hypothalamic-pituitary-adrenal axis and is affected by anxiety, depression, and drugs used to treat these disorders, yet receptor signaling mechanisms operative in hypothalamus prior to maturation remain to be elucidated. In peripubertal male rats, systemic injection of the selective serotonin 1A (5-HT) receptor agonist (+)8-OH-DPAT (0.2 mg/kg) markedly elevated plasma levels of oxytocin and adrenocorticotropic hormone (ACTH) at 5 and 15 min post-injection. The 5-HT receptor selectivity was demonstrated by the ability of the 5-HT receptor selective antagonist WAY100635 to completely block both oxytocin and ACTH responses at 5 min, with some recovery of the ACTH response at 15 min. At 15 min post-injection, (+)8-OH-DPAT also increased levels of phosphorylated extracellular signal-regulated kinase (pERK) and phosphorylated protein kinase B (pAkt) in the PVN. As previously observed in adults, (+)8-OH-DPAT reduced levels of pERK in hippocampus. WAY100635 also completely blocked (+)8-OH-DPAT-mediated elevations in hypothalamic pERK and pAkt and the reductions in hippocampal pERK, demonstrating 5-HT receptor selectivity of both kinase responses. This study provides the first demonstration of functional 5-HT receptor-mediated ERK and Akt signaling pathways in the immature hypothalamus, activated by a dose of (+)8-OH-DPAT that concomitantly stimulates neuroendocrine responses. This information is fundamental to identifying potential signaling pathways targeted by biased agonists in the development of safe and effective treatment strategies in children and adolescents.
越来越多的证据表明,多种因素会对未成熟的大脑产生影响,这些影响与成年人大脑的影响不同,且更为持久。下丘脑室旁核(PVN)是下丘脑-垂体-肾上腺轴的一个重要组成部分,它受到焦虑、抑郁和用于治疗这些疾病的药物的影响,但在成熟之前作用于下丘脑的受体信号机制仍有待阐明。在青春期前的雄性大鼠中,全身注射选择性 5-羟色胺 1A(5-HT)受体激动剂(+)8-OH-DPAT(0.2mg/kg)可在注射后 5 和 15 分钟显著提高催产素和促肾上腺皮质激素(ACTH)的血浆水平。5-HT 受体的选择性通过 5-HT 受体选择性拮抗剂 WAY100635 的能力来证明,它可以在 5 分钟时完全阻断催产素和 ACTH 的反应,在 15 分钟时 ACTH 的反应有一定程度的恢复。在注射后 15 分钟,(+)8-OH-DPAT 还增加了 PVN 中磷酸化细胞外信号调节激酶(pERK)和磷酸化蛋白激酶 B(pAkt)的水平。如先前在成年人中观察到的那样,(+)8-OH-DPAT 降低了海马体中 pERK 的水平。WAY100635 还完全阻断了(+)8-OH-DPAT 介导的下丘脑 pERK 和 pAkt 的升高以及海马体 pERK 的降低,证明了两种激酶反应的 5-HT 受体选择性。这项研究首次证明了功能性 5-HT 受体介导的 ERK 和 Akt 信号通路在未成熟下丘脑的存在,这种信号通路是由(+)8-OH-DPAT 的剂量激活的,该剂量同时刺激神经内分泌反应。这一信息对于确定有偏见的激动剂在儿童和青少年安全有效的治疗策略的发展中针对的潜在信号通路是至关重要的。